- Chanca piedra is a plant found in the Amazon rainforests and other tropical areas. It can grow to a height of 30-40 centimeters.
- Chanca piedra has a history in herbal medicine. It has been used to treat bacterial infections, diabetes, hepatitis, high blood pressure, liver diseases, and viral infections, as well as bile duct, intestine, liver, stomach, and urinary conditions.
- At this time, there is a lack of studies to support chanca piedra for any use. Early research suggests its abilities to fight viruses, prevent formation of calculi (mineral stones in organs), protect the liver, and reduce blood sugar and blood pressure. Additional information is needed in these areas.
← Back to Monographs
ingredients
Chancapiedra
Contents
- Boim, M. A., Heilberg, I. P., and Schor, N. Phyllanthus niruri as a promising alternative treatment for nephrolithiasis. Int.Braz.J Urol. 2010;36(6):657-664. View Abstract
- Celia A, Micali S Sighinolfi M et al. May phyllanthus niruri (Uriston®) affect the efficacy of ESWL on renal stones? A prospective, randomised short term study [abstract no: 178] . The Cochrane Library 2005;(1)
- Dirjomuljono, M., Kristyono, I., Tjandrawinata, R. R., and Nofiarny, D. Symptomatic treatment of acute tonsillo-pharyngitis patients with a combination of Nigella sativa and Phyllanthus niruri extract. Int.J Clin Pharmacol.Ther. 2008;46(6):295-306. View Abstract
- Doshi, J. C., Vaidya, A. B., Antarkar, D. S., Deolalikar, R., and Antani, D. H. A two-stage clinical trial of Phyllanthus amarus in hepatitis B carriers: failure to eradicate the surface antigen. Indian J Gastroenterol. 1994;13(1):7-8. View Abstract
- Huang ZR, Zhong JP, and Zhu GL. Therapeutic observation of Phyllanthus amarus for treatment of hepatitis B . The Cochrane Library 1993;(1)
- Jayaram S, Thyagarajan SP Sumathi S et al. Efficacy of Phyllanthus amarus treatment in acute viral hepatitis A, B and non A non B: an open clinical trial. Indian Journal of Virology 1997;13(1):59-64.
- McPartland JM. Viral hepatitis treated with Phyllanthus amarus and milk thistle (Silybum marianum): a case report [corrected]. Complementary Medicine International 1996;3(2):40-42.
- Milne, A., Hopkirk, N., Lucas, C. R., Waldon, J., and Foo, Y. Failure of New Zealand hepatitis B carriers to respond to Phyllanthus amarus. N.Z.Med J 6-22-1994;107(980):243. View Abstract
- Moshi, M. J., Lutale, J. J., Rimoy, G. H., Abbas, Z. G., Josiah, R. M., and Swai, A. B. The effect of Phyllanthus amarus aqueous extract on blood glucose in non-insulin dependent diabetic patients. Phytother.Res 2001;15(7):577-580. View Abstract
- Narendranathan, M., Remla, A., Mini, P. C., and Satheesh, P. A trial of Phyllanthus amarus in acute viral hepatitis. Trop.Gastroenterol. 1999;20(4):164-166. View Abstract
- Nishiura, J. L., Campos, A. H., Boim, M. A., Heilberg, I. P., and Schor, N. Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients. Urol.Res 2004;32(5):362-366. View Abstract
- Patel HJ, Patel JS Patel KN. Clinical study of hepatoprotective drug Phyllanthus amarus. Research Journal of Pharmaceutical Biological and Chemical Sciences. Research Journal of Pharmaceutical Biological and Chemical Sciences 2010;335-340.
- Wang XH, Li CQ Guo XB et al. Clinical observation on 40 cases of chronic hepatitis B using compound Phyllanthus amarus combined with interferon. Chinese Journal of Integrated Traditional & Western Medicine on Liver Diseases 1999;12-31.
- Xin-Hua, W., Chang-Qing, L., Xing-Bo, G., and Lin-Chun, F. A comparative study of Phyllanthus amarus compound and interferon in the treatment of chronic viral hepatitis B. Southeast Asian J Trop.Med Public Health 2001;32(1):140-142. View Abstract
- Zhang JL, He WN Ye P. Clinic observation on Phyllanthus amarus for treating chronic HBV infection. Chinese Journal of Integrated Traditional & Western Medicine on Liver Diseases 1992;8-10.
Disclaimer: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.
